IDI Says The Use Of Medical Marijuana Still Needs In-depth Study, Check Out The Explanation

UNSPLASH ILLUSTRATION

JAKARTA - General Chair of the Indonesian Doctors Association (PB IDI) dr. M. Adib Khumaidi, SpOT said that the current use of medical marijuana still requires an in-depth study to ensure patient safety and security.

"We have to really review this because anything that is given to us, especially medicine, there will definitely be side effects and that must be our concern," said Adib after the opening of the World Medical Doctors Association Conference in Jakarta as reported by BETWEEN, Monday, July 4th.

Adib continued, new drugs must be based on clinical evidence. According to him, it is necessary to study whether these drugs can be used as main drugs, supporting drugs given at the same time as other drugs, or alternative drugs if the previous treatment did not work.

"We have to understand this because in the management of a disease there is a golden standard, which one we have to treat and which one to treat. Everything goes through an evidence-based process," Adib explained.

"So we have to really evaluate it in the form of research, because our current interest is patient safety," he said.

The research process, said Adib, includes various stages including the collection of existing scientific journals to be used as references, data analysis, to the clinical trial stage.

Adib said IDI was ready to collaborate with the Ministry of Health to collaborate on a scientific study on medical marijuana.

"Together with the Ministry of Health, we are ready to collaborate, to actually make a study based on research on this. But the most important thing is, of course, we have to do treatments that have become the golden standard," said Adib.

"I think later we can also involve experts, such as pharmacology experts to carry out this study. Then research institutions, all of them, I think will be involved," he said.